To obtain more insight into the physiological role of gamma-aminobutyric acid (GABA) in rat salivary glands, we measured the concentration of GABA and the activities of its biosynthetic and metabolic enzymes, glutamate decarboxylase (GAD) and GABA transaminase (GABA-T). The GABA concentrations in rat parotid and submandibular glands were 10.0 and 14.3 nmol/g weight, respectively, which were 0.6-0.8% of the levels in the brain (cerebellum and medulla oblongata), whereas glutamic acid (Glu) was abundant in the two glands. These GABA levels in the two glands were significantly decreased by administration of semicarbazide (200 mg/kg, i.p.), a GAD inhibitor, and increased by gabaculine (50 mg/kg, i.p.), a GABA-T inhibitor. The activities of both GAD and GABA-T were also detected in homogenates of the two salivary glands, but they were lower than those in the brain. However, kinetic analysis showed that the values of Michaelis constants for Glu and GABA in both enzyme reactions in these two glands were similar to those in the brain. These results indicate that GABA and its biosynthetic and metabolic enzymes are present in rat salivary glands as well as the brain.
Gamma-aminobutyric acid (GABA), which is formed from L-glutamic acid (Glu) by the action of glutamate decarboxylase (GAD; EC 4.1.1.15) and is metabolized to succinic semialdehyde by transamination with a-ketoglutarate catalyzed by a GABA transaminase (GABA-T; EC 2.6.1. 19) , is generally present in nerve tissue of mammals and plays an important inhibitory role therein (1) (2) (3) . GABA, GAD and GABA-T are not limited to the central nervous system but are also found in peripheral tissues such as kidney, liver, adrenal gland, heart and uterus, although their levels there are much lower than those in the brain (4) (5) (6) . These findings indicate that GABA may serve diverse physiological functions in peripheral tissues as it does in the central nervous system (7) . For example, in the pancreas, GABA produced in 3 cells inhibits glucagon secretion by a cells (8) ; GABA also stimulates production of testosterone in the testes (9) . However, the functional role of GABA in many peripheral tissues (e.g., salivary glands) has not yet been clearly defined. Recently, we have found that diazepam, a benzodiazepine compound, suppressed salivary secretion induced by pilocarpine in the rat in vivo and that in rat parotid acinar cells, diazepam accelerated 36C1-influx and inhibited its efflux. The effects of diazepam on 36C1-influx were further enhanced by muscimol and GABA (10, 11) . These findings led us to the suggestion that at least two receptors for benzodiazepine and GABA exist in rat parotid gland membranes and that GABA may act as a regulatory factor in inhibitory mechanisms of salivary secretion induced by benzodiazepines.
In the present study, we measured the GABA content and those of its biosynthetic and metabolic enzymes in rat salivary glands.
MATERIALS AND METHODS

Animals
Male Wistar rats (Japan SLC, Inc., Hamamatsu), weighing 230 -270 g, were used. The animals were kept at a constant room temperature with a 12-hr light-dark cycle and maintained on commercial laboratory chow and tap water.
Chemicals
GABA, gabaculine, leupeptin, antipain, pepstatin A and aprotinin were obtained from Sigma Chemical Co.
(St. Louis, MO, USA). Semicarbazide and Glu were from Nacalai Tesque (Kyoto) and Wako Pure Chem. Ind.
(Osaka), respectively. All other reagents were of the highest analytical grade available.
Preparation for GABA and Glu determination
Rats were killed by diethyl ether anesthesia and subsequent cardiac puncture. The parotid gland, submandibular gland, cerebellum and medulla oblongata were quickly removed and frozen in acetone and dry ice. All tissue samples were immediately weighed and homogenized in 5 -10 volumes of ice-cold methanol with a polytron homogenizer. The homogenate was centrifuged at 15,000 x g for 10 min at 41C, and the clear supernatant was kept for analysis. GABA and Glu were estimated by high-performance liquid chromatography (HPLC) with fluorescence detection, with O-phthalaldehyde (OPA) used as a precolumn amino acid-derivatizing agent (12) . A 60-pl portion of the supernatant prepared by centrifugation was mixed with 20 pl of 4 mM OPA dissolved in 0.1 M sodium tetraborate (pH 9.5) containing 0.0004% 2-mercaptoethanol.
An aliquot (10-20 p1) of this mixture was injected into an HPLC after 2 min of development of the OPA derivatives. The contents of GABA and Glu were quantified by comparison with the standard curves for each amino acid. Recoveries of each amino acid standard added to tissue homogenates were found to be over 90%.
Preparation of enzyme solution
The four tissues were removed from the rats as described above, and a 10-20% homogenate was prepared in ice-cold 0.25 M sucrose solution containing 50 mM potassium phosphate (pH 7.2), 0.2 mM pyridoxal phosphate, 1 mM 2-aminoethylisothiouronium bromide (AET) and protease inhibitors: leupeptin (5 pg/ml), antipain (5 pg/ml), pepstatin A (5 pg/ml) and aprotinin (10 pl/ml). The homogenate was centrifuged at 900 x g for 15 min at 41C, and the supernatant liquid obtained was used for the assay of enzymes.
HPLC system
A model LC-5A chromatographic system from Shimadzu Seisakusho, Ltd. (Kyoto) was combined with a spectro-fluorometric detector (model RF-530, Shimadzu Seisakusho, Ltd.). The analysis of amino acids was performed by separation on a reverse phase column, Eicompak MA-SODS (4.6 x 150 mm i.d.; Eicom Co. Ltd., Kyoto), which was operated at 40'C. For the determination of GABA and Glu, two types of eluent were used with a flow rate of 1.0 ml/min: 0.05 M sodium phosphate (pH 3.5) containing 50% methanol for the GABA elution and 0.05 M sodium phosphate (pH 6.0) containing 18% methanol for the Glu elution. The fluorescence of the GABA and Glu eluates was measured spectrofluorometrically at the emission wavelength of 445 nm and at the excitation wavelengths of 340 and 360 nm, respectively.
Enzyme assay
The activities of GAD and GABA-T were measured according to the methods described by Wu et al. (13) and Schousboe et al. (14) , respectively, with some modifications. GAD was assayed in a total volume of 0.75 ml containing 0.1 M potassium phosphate (pH 7.2), 20 mM Glu, 0.2 mM pyridoxal phosphate and enzyme solution (approx. 0.2 -5.4 mg protein). After incubation at 371C for 30 min, the reaction mixture was mixed with 0.35 ml of ice-cold methanol and kept on ice. GABA-T was assayed in a total volume of 0.7 ml containing 0.1 M Tris/HC1 (pH 8.0), 0.2 mM pyridoxal phosphate, 0.1 mM AET, 10 mM a-ketoglutaric acid, 30 mM GABA and enzyme solution (approx. 0.2-4.6 mg protein). After incubation at 37V for 30 min, the reaction mixture was mixed with 0.4 ml of ice-cold methanol and kept on ice. After both enzyme reactions, the precipitated proteins were removed by centrifugation, and the GABA formed in the GAD reaction and the Glu formed in the GABA-T reaction were measured by the HPLC method described above. GABA and Glu values were further estimated by subtracting the values of blanks ran without Glu and GABA. The kinetic properties of GAD and GABA-T were determined by the method of Lineweaver and Burk (15) ; concentrations of Glu and GABA ranging from 0.1 to 10 mM were used.
Protein determination
Protein was determined according to the method of Lowry et al. (16) with bovine serum albumin as a standard.
Statistics
Statistical analyses were performed by the two-tailed Student's t-test. P values less than 0.05 were considered statistically significant. Table 1 reveals that the concentrations of GABA in rat parotid and submandibular glands are lower than those in the brain (cerebellum and medulla oblongata). These values were 0.6-0.8% of those in the brain (cerebellum) and were similar to the previously reported values for rat liver, heart, skeletal muscle, and diaphragm (4, 5) . We also measured the concentrations of Glu in these four rat tissues. The Glu values (mean±S.E.) were 3.55±0.13 Table 1 . Concentration of gamma-aminobutyric acid (GABA) in rat salivary glands and the brain Each value is a mean±S.E. a: 100 x tissue levels/cerebellum levels.
RESULTS
GABA content in rat salivary glands
pmol/g weight for the parotid gland, 3.28 ± 0.12 pmol/g weight for the submandibular gland, 9.43 ± 0.18 pmol/g weight for the cerebellum and 6.50±0.34 pmol/g weight for the medulla oblongata. In the parotid and submandibular glands, the Glu contents were approximately 300 times higher than the GABA contents and were comparable to brain levels.
Effect of semicarbazide and gabaculine on GABA level in rat salivary glands To determine whether GABA biosynthetic and/or metabolic pathways are present in rat salivary glands, we first measured GABA levels after administration of inhibitors of enzymes coupled to their pathways. GABA levels in the four rat tissues observed were significantly decreased by administration of semicarbazide, which is a GAD inhibitor and is used to decrease GABA levels in the brain (Table 2) . Semicarbazide resulted in a somewhat similar Table 2 . Effects of semicarbazide and gabaculine on gammaaminobutyric acid (GABA) levels in rat salivary glands and the brain reduction in the four tissues; i.e., there was a decrease of 42-6001o of GABA in the parotid and submandibular glands and a 42-45% decrease in the brain tissues. Administration of gabaculine, a potent inhibitor of GABA-T, led to increasing GABA levels in the brain and produced a significant increase in GABA levels in the parotid and submandibular glands as well ( Table 2) . GABA levels in the brain were 12 times higher than levels in the drug-untreated animals, but those in two salivary glands were only approximately 2 times as high. These results imply that GABA biosynthetic and metabolic enzymes exist in these two rat salivary glands as well as in the brain, although the effects of gabaculine on changes in GABA levels in the brain and salivary glands were slightly different.
GAD and GABA-T activities in rat salivary glands
Next, we directly measured the activities of GAD and GABA-T in these two rat salivary glands. Their activities could be detected in assays of crude homogenates of parotid and submandibular glands ( Table 3 ). The specific activities of GAD and GABA-T in the two salivary glands were also lower than those of brain enzymes, equal to approximately 0.04 -0.06010 and 3 -13 010, respectively, of those in the brain (cerebellum).
Kinetic properties of GAD and GABA-T
We further investigated some of the characteristics of GAD and GABA-T in the two salivary glands. In the homogenates of both parotid and submandibular glands, the maximal velocities (Vm) for GAD and GABA-T obtained from the Lineweaver-Burk plot were appreciably lower than those in the brain as measured by the same assay technique. However, the apparent Michaelis constants (Km) for Glu and GABA in the two enzyme reactions were calculated to be 0.4-0.7 mM and 1.1-1.5 mM, respectively, similar to those obtained from brain homogenates ( Table 4 ). 
DISCUSSION
In the present study, we found that in rat parotid and submandibular glands, the GABA contents were approximately 0.6-0.8% of brain levels (Table 1) , whereas the Glu contents were comparable to those in the brain. We also detected the activities of GABA biosynthetic and metabolic enzymes, GAD and GABA-T, in the homogenates of these two salivary glands at levels lower than those in the brain (Table 3 ). Our data for GABA and Glu concentrations obtained from rat brain in this study were in fair agreement with previously reported results (17) . We thus conclude that smaller but detectable amounts of GABA and its biosynthetic and metabolic enzymes are present in salivary glands of the rat. This conclusion is strongly supported by the changes in GABA levels after administration of semicarbazide and gabaculine, which are GAD and GABA-T inhibitors and which respectively produced a significant decrease and an increase in GABA levels in the two salivary glands ( Table 2 ). Our data also suggest that the GABA, GAD and GABA-T found in two rat salivary glands are associated with a functional role of the tissue itself.
GABA, GAD and GABA-T are found in several peripheral tissues such as the kidney, heart, liver, lung, pancreas, oviduct, testis and adrenal gland (4 -6) . Mammalian tissues contain at least two types of GAD with respect to characteristic activity by anions, biochemical properties, molecular size and subcellular location (18, 19) . For example, GADs in the oviduct, adrenal gland and pancreas are similar to brain GAD, whereas GADs in the heart, kidney and liver are different (20) (21) (22) (23) . We did not determine whether the two enzymes we found in rat parotid and submandibular glands were the same as the brain enzymes, but we found that the substrate kinetic values with GAD and GABA-T in the two salivary glands were similar to those of the brain enzymes (Table 4 ). Furthermore, the Km values for Glu and GABA in Table 4 were similar to those reported for the enzymes of mouse brain (13, 14) , rat brain (24) and human brain (4) . Thus, our data suggest that the GAD and GABA-T found in these two rat salivary glands are similar to brain enzymes with respect to substrate affinities. There is an essentially linear relationship between GABA content and GAD activity in various brain areas; the steady state concentration of GABA is controlled by GAD activity but not by GABA-T activity (25) . The two salivary glands were wellsaturated with Glu as a substrate for GAD, and its contents (3.28 -3.55 pmol/g weight) were higher than the Km values for GAD, while the activities of GAD and GABA-T and Vmax values for GAD and GABA-T were low (Tables  3 and 4 ). Therefore, it is generally thought that in the salivary glands, the GABA contents are also controlled by GAD activity, whereas GABA-T activity is dependent on the GABA contents. It is considered that the distribution of GABA and GAD in peripheral tissues indicates that GABA may have some physiological function other than neurotransmission (6) . There is now increasing evidence to support the proposal that GABA is a signaling molecule in both neural and peripheral tissues (6) . For example, the involvement of GABA in hormonal functions in endocrine tissues such as the pancreas, adrenal gland, thyroid gland and ovary has been reported (6) . At present, the physiological role of GABA in rat parotid and submandibular glands is unknown. However, we have recently found that: (i) Diazepam strongly suppressed salivary secretion induced by pilocarpine in the rat in vivo; (ii) In rat parotid acinar cells, diazepam stimulated 36C1-influx; this effect was further enhanced by muscimol and GABA; and (iii) Diazepam also inhibited 36C1-efflux in these cells (10, 11) . These findings suggested that GABA in the two salivary glands may be related to the inhibitory mechanisms of salivary secretion induced by benzodiazepines. Recently, in rat salivary gland membranes, the existence of the central and peripheral types of benzodiazepine receptors and GABAA receptors coupled with the central type of benzodiazepine receptors has been shown by radioreceptor assay with diazepam and muscimol (26) . It has also been reported that in the perfused rat submandibular glands, GABA at 10-6 mol inhibits the secrection of saliva under electrical stimulation via GABAA receptors (27) . Their results indicate that GABA and its receptors may play a physiological role in the regulation of salivation and strongly support the involvement of GABA in the inhibitory mechanisms of salivary secretion by benzodiazepines. Furthermore, to elucidate the relationship between GABA and the action of benzodiazepines, it is necessary to investigate the influence of benzodiazepines on GABA levels and its biosynthetic and metabolic enzymes in rat salivary glands.
In conclusion, our present data show that GABA and its biosynthetic and metabolic enzymes are present in rat salivary glands, although at much lower levels than in the brain.
